Items where Division is "Current Faculties > Faculty of Medicine > Clinical and Experimental Sciences > Innate Immunology
Clinical and Experimental Sciences > Innate Immunology" and Year is 2024
 | Up a level |
Number of items: 11.
Article
Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2 - Joseph A. Bell, Elizabeth R. Davies, Christopher J. Brereton, Milica Vukmirovic, James J.W. Roberts, Kerry Lunn, Leanne Wickens, Franco Conforti, Robert A. Ridley, Jessica Ceccato, Lucy N. Sayer, David A. Johnston, Andres F. Vallejo, Aiman Alzetani, Sanjay Jogai, Ben G. Marshall, Aurelie Fabre, Luca Richeldi, Phillip D. Monk, Paul Skipp, Naftali Kaminski, Emily Offer, Yihua Wang, Donna E. Davies and Mark Jones
Type: Article
| 2024
Three-dimensional culture modelling reveals divergent Mycobacterium tuberculosis virulence and antimicrobial treatment response - Magdalena K. Bielecka, Liku B. Tezera, Eleni Konstantinopoulou, Nicola Casali, Orestis L. Katsamenis, Ximena Gonzalo, Francis Drobniewski and Paul T. Elkington
Type: Article
| 2024
The nuclear export protein XPO1 provides a peptide ligand for natural killer cells - Matthew D. Blunt, Hayden Fisher, Ralf B. Schittenhelm, Berenice Mbiribindi, Rebecca Fulton, Sajida Khan, Laura Espana-Serrano, Lara V. Graham, Leidy Bastidas-Legarda, Daniel Burns, Sophie M.S. Khakoo, Salah Mansour, Jonathan W. Essex, Rochelle Ayala, Jayajit Das, Anthony W. Purcell and Salim I. Khakoo
Type: Article
| 2024
Harnessing natural killer cell effector function against cancer - Matthew D. Blunt and Salim I. Khakoo
Type: Article
| 2024
NK cells in the lymph nodes and their role in anti-tumour immunity - Lara V. Graham, Salim I. Khakoo and Matthew D. Blunt
Type: Article
| 2024
B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles - Robert Krause, Paul Ogongo, Liku Tezera, Mohammed Ahmed, Ian Mbano, Mark Chambers, Abigail Ngoepe, Magalli Magnoumba, Daniel Muema, Farina Karim, Khadija Khan, Kapongo Lumamba, Kievershen Nargan, Rajhmun Madansein, Adrie Steyn, Alex K. Shalek, Paul Elkington and Al Leslie
Type: Article
| 2024
Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers - Hannah Schiff, Naomi F. Walker, Cesar Ugarte-Gil, Marc Tebruegge, Spiros D. Garbis, Antigoni Manousopoulou, Salah Mansour, Pak Ho Wong, Gabrielle Rockett, Paolo Piazza, Mahesan Niranjan, Andres F. Vallejo, Christopher H. Woelk, Robert J. Wilkinson, Liku B. Tezera, Diana Garay Baquero and Paul Elkington
Type: Article
| 2024
Letter
Targeting CD161 in B-cell malignancies - Matthew D. Blunt
Type: Letter
| 2024
Editorial
Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity - Jack G. Fisher, Lara V. Graham and Matthew D. Blunt
Type: Editorial
| 2024
| Item not available on this server.
Review
Pathogenesis of post-tuberculosis lung disease: defining knowledge gaps and research priorities at the 2nd International Post-Tuberculosis Symposium - Sara C. Auld, Amy K. Barczak, William Bishai, Anna K. Coussens, Intan M.W. Dewi, Steven C. Mitini-Nkhoma, Caleb Muefong, Threnesan Naidoo, Anil Pooran, Cari Stek, Adrie J.C. Steyn, Liku Tezera and Naomi F. Walker
Type: Review
| 2024
| Item availability restricted.
Particles in Exhaled Air (PExA): clinical uses and future implications - Thomas Roe, Siona Silveira, Zixing Luo, Eleanor L. Osborne, Ganapathy Senthil Murugan, Michael P.W. Grocott, Anthony D. Postle and Ahilanandan Dushianthan
Type: Review
| 2024